126 results on '"Olshen, Adam B"'
Search Results
2. Supplementary Figure 6 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
3. Supplementary Data from Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET-Amplified Tumor Cells with or without Resistance to Selective MET Inhibition
4. Supplementary Figure 6 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
5. Supplementary Methods from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
6. Supplementary Figures 1-5 and 7-10 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
7. Supplementary Figures 1-5 and 7-10 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
8. Supplementary Tables 1-14 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
9. Supplementary Methods from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
10. Supplementary Tables 1-14 from Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
11. Supplementary Table 1-5 from Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors
12. Data from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
13. Supplementary Array Data from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
14. Supplementary Array Data from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
15. Data from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
16. Supplementary Figures 1-7 from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
17. Supplementary Figures 1-4 from Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors
18. Supplementary Table 1 from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
19. Supplementary Tables 3A-6A from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
20. Supplementary Table 1-5 from Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors
21. Supplementary Figures 1-4 from Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors
22. Supplementary Figures 1-7 from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
23. Supplementary Table 1 from Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
24. Supplementary Figures 1-3 from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
25. Supplementary Figures 1-3 from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
26. Supplementary Tables 3A-6A from Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction
27. Epigenetic Regulation of Inflammatory Mechanisms and a Psychological Symptom Cluster in Patients Receiving Chemotherapy
28. Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
29. Does multi-way, long-range chromatin contact data advance 3D genome reconstruction?
30. Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia
31. A Transcriptional Classifier Identifies Pediatric T-Cell Acute Lymphoblastic Leukemias at High Risk for End of Induction Minimal Residual Disease
32. Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy
33. A TARGETED GENE EXPRESSION CLASSIFIER IDENTIFIES PEDIATRIC T-ALL PATIENTS AT HIGH RISK FOR END INDUCTION MINIMAL RESIDUAL DISEASE POSITIVITY
34. Gastrointestinal Symptom Cluster is Associated With Epigenetic Regulation of Lymphotoxin Beta in Oncology Patients Receiving Chemotherapy
35. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women
36. COVIDNearTerm: A Simple Method to Forecast COVID-19 Hospitalizations
37. Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors
38. Discovering dominant tumor immune archetypes in a pan-cancer census
39. Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
40. COVIDNearTerm: A Simple Method to Forecast COVID-19 Hospitalizations
41. Targeted gene expression classifier identifies pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients at high risk for end induction minimal residual disease positivity.
42. In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system
43. A Pan-Cancer Census of Dominant Tumor Immune Archetypes
44. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia
45. Associations Among Multiple Markers and Complex Disease: Models, Algorithms, and Applications
46. Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering
47. Genetic Alterations Precede DNA Methylation Changes in Juvenile Myelomonocytic Leukemia
48. Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature
49. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features
50. Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.